Applied Biosystems introduces two new genetic analyzers

Applied Biosystems, a division of Life Technologies Corporation, has announced the expansion of its industry-leading portfolio of capillary electrophoresis sequencing systems with the introduction of two new lines of genetic analyzers.

Photo: Applied Biosystems introduces two new genetic analyzers

The 3500 Series, for research use only, will be available worldwide, while the 3500 Dx Series is intended for clinical use, and will initially be launched in specific countries within the European Union. Both platforms will provide state-of-the-art advancements in CE sequencing systems, setting significant new standards for throughput, data quality and ease of use.

Currently, researchers use DNA sequencing as a method for identifying genetic variation. Scientists participating in an early evaluation of the technology are interested in studying the most widely recognised human genetic disorders, such as those caused by extra or missing chromosomes, as well as a broad spectrum of other disorders. Some of these data were presented at the European Society of Human Genetics meeting in Vienna, Austria.

3500 Dx Series Genetic Analyzers
The 3500 Dx Series Genetic Analyzers are intended for use by trained operators in the analysis of human DNA or RNA, for the detection of genetic changes that may lead to disease presence or

susceptibility. This system will be distributed and used in specific European countries only, including France, Germany, Italy, the Netherlands, Spain, Sweden, and the United Kingdom. It represents the first CE system and accessories to comply with the European Union In Vitro Diagnostic Medical Devices Directive 98/79/EC. Commercial launch of the 3500 Dx Series Systems is anticipated in August 2009.

3500 Series Genetic Analyzers (For Research Use Only)
The 3500 Series enables researchers to run up to 1,100 sequencing or 1,200 genotyping samples per day. It features novel consumable designs, incorporating the ability to track key information with radio frequency identification (RFID) tags, new optical and thermal systems designs, and redesigned data collection and analysis software, which enables easy generation of cost-effective analyses and high-quality data. The 3500 Series Systems are for research use only, and are anticipated to be commercially available in August 2009.
 

27.05.2009

More on the subject:

Related articles

Photo

News • Pharmaceutical Automation and Digitalisation Congress

Why Clinical Trial Data Integration Is Becoming a High Priority for Pharma R&D

Discussion at the Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2026 recognises that artificial intelligence is an important part of clinical innovation, positioning it as a…

Photo

News • Open-source AI models put to the test

LLMs outperform doctors at summarizing complex cancer pathology reports

AI models can generate more complete summaries of complex cancer pathology reports than physicians, according to a new study that tested six models developed by Meta, Google, DeepSeek and Mistral AI.

Photo

News • AI-enabled ambient documentation

Do AI scribes prevent clinician burnout? Yes, but...

AI-enabled ambient documentation shows great promise for reducing doctors' workload – but how big is their impact on burnout prevention really? A new study reveals modest time-saving effects.

Subscribe to Newsletter